ACG Wealth’s Boston Scientific BSX Stock Holding History

ACG Wealth’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4	Closed	–	–	331
2022 Q2	$0	Buy	+4	New	+$163	﹤0.01%	926

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

ACG Wealth's BSX Position: Q3 2022 in Review

ACG Wealth sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 4 shares.

ACG Wealth first reported a position in BSX in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

ACG Wealth reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 4 Boston Scientific shares in Q3 2022.
ACG Wealth first reported a position in Boston Scientific in Q2 2022 and held it in 1 quarter.
ACG Wealth's Boston Scientific position peaked at $0 in Q2 2022.
864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.